| Rus |  |
Eng |  |
Research scientist Maksym Plakhothyuk from research group led by Professor Leon Mishnaevsky in Technical University of Denmark (DTU), visited Ukrainian partner Materials Research Centre, Kiev, Ukraine on September-November 2018, due to due to the Horizon-2020 prgram, Maria Sklodovska Curie Actions Research and Innovation Staff Exchange, NANO2DAY research project.
The aim of NANO2DAY project is to develop novel multifunctional composites with outstanding electronic and mechanical properties by incorporation of novel MXene nanosheets into polymer matrixes. In close collaboration with Ukrainian researchers from Materials Research Centre, Maksym Plakhotnyuk worked on NANO2DAY project activities integrating in research infrastructure of MRC project partner, participated in nanomaterials synthesis and nanomaterials preparation. Also researcher Maksym Plakhotnyuk participated on studying the issues of multiscale simulation and testing of composite materials for further calculation and simulation of their mechanical strength properties.
The Technical University of Denmark (DTU) ranks as the best Scandinavian and 11th best European university in technology. The Section of Composites and Materials Mechanics has great experience in composite materials for wind turbines, and has expertise in multiscale simulation and testing of composite materials.
Read more about NANO2DAY project:
 H2020-MSCA-RISE project „Multifunctional polymer composites doped with novel 2D nanoparticles for advanced applications NANO2DAY” started on May 1, 2018. It is aimed to develop novel multifunctional composites with outstanding electronic and mechanical properties by incorporation of novel MXene nanosheets into polymer matrixes. |
|
Professor Omastova was acquainted with the activities and research infrastructure of MRC project partner, she held several seminars on polymer composites and talked about the experience and developments of her institute. During her visit project participants held several project meetings to discuss further research works, MXene synthesis and MXene-doped polymer composites. |
Professor Maria Omastova from Polymer Institute, Slovak Academy of Science, Bratislava, Slovakia, visited Materials Research Centre, Kiev, Ukraine, in July-August 2018 due to the Horizon-2020 prgram, Maria Sclodovska Curie Actions Research and Innovation Staff Exchange, NANO2DAY research project.
|
|
NANO2DAY project participants from Materials Research Centre, Kiev, Ukraine, MRC director and project leader Oleksiy Gogotsi and ESR Veronika Zahorodna are working in Polymer Institute, Slovak Academy of Sciences, Bratislava, Slovakia under the project secondments plan. MRC project participants work in close cooperation with researchers from Polymer Institute, share their experience in two-dimesional nanomaterials (MXene) synthesis and take over the experience and study the developments of colleagues on polymers and composite materials.
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
